[go: up one dir, main page]

GB201807376D0 - HMCV Vaccine Composition - Google Patents

HMCV Vaccine Composition

Info

Publication number
GB201807376D0
GB201807376D0 GBGB1807376.7A GB201807376A GB201807376D0 GB 201807376 D0 GB201807376 D0 GB 201807376D0 GB 201807376 A GB201807376 A GB 201807376A GB 201807376 D0 GB201807376 D0 GB 201807376D0
Authority
GB
United Kingdom
Prior art keywords
hmcv
vaccine composition
vaccine
composition
hmcv vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1807376.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spybiotech Ltd
Original Assignee
Spybiotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spybiotech Ltd filed Critical Spybiotech Ltd
Priority to GBGB1807376.7A priority Critical patent/GB201807376D0/en
Publication of GB201807376D0 publication Critical patent/GB201807376D0/en
Priority to JP2021510553A priority patent/JP7575096B2/en
Priority to AU2019263706A priority patent/AU2019263706A1/en
Priority to PCT/GB2019/051245 priority patent/WO2019211630A2/en
Priority to EP19723480.0A priority patent/EP3787676A2/en
Priority to BR112020022393-0A priority patent/BR112020022393A2/en
Priority to CA3099381A priority patent/CA3099381A1/en
Priority to SG11202010821TA priority patent/SG11202010821TA/en
Priority to KR1020207034602A priority patent/KR20210013571A/en
Priority to CN202510197781.6A priority patent/CN120040601A/en
Priority to US17/052,707 priority patent/US12433944B2/en
Priority to CN201980044956.2A priority patent/CN112638411B/en
Priority to IL278418A priority patent/IL278418B2/en
Priority to JP2024133744A priority patent/JP2024156964A/en
Priority to US19/323,644 priority patent/US20260007740A1/en
Ceased legal-status Critical Current

Links

GBGB1807376.7A 2018-05-04 2018-05-04 HMCV Vaccine Composition Ceased GB201807376D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1807376.7A GB201807376D0 (en) 2018-05-04 2018-05-04 HMCV Vaccine Composition
IL278418A IL278418B2 (en) 2018-05-04 2019-05-03 A vaccine
CA3099381A CA3099381A1 (en) 2018-05-04 2019-05-03 Vaccine composition
KR1020207034602A KR20210013571A (en) 2018-05-04 2019-05-03 Vaccine composition
PCT/GB2019/051245 WO2019211630A2 (en) 2018-05-04 2019-05-03 Vaccine composition
EP19723480.0A EP3787676A2 (en) 2018-05-04 2019-05-03 Vaccine composition
BR112020022393-0A BR112020022393A2 (en) 2018-05-04 2019-05-03 composition, vaccine comprising a composition, method for producing a composition, nucleic acid molecule, and, vector, host cell, kit comprising a composition, and, vaccines for use in the prophylaxis and / or treatment of cytomegalovirus and respiratory syncytial virus infection .
JP2021510553A JP7575096B2 (en) 2018-05-04 2019-05-03 Vaccine Compositions
SG11202010821TA SG11202010821TA (en) 2018-05-04 2019-05-03 Vaccine composition
AU2019263706A AU2019263706A1 (en) 2018-05-04 2019-05-03 Vaccine composition
CN202510197781.6A CN120040601A (en) 2018-05-04 2019-05-03 Vaccine composition
US17/052,707 US12433944B2 (en) 2018-05-04 2019-05-03 Vaccine composition
CN201980044956.2A CN112638411B (en) 2018-05-04 2019-05-03 Vaccine composition
JP2024133744A JP2024156964A (en) 2018-05-04 2024-08-09 Vaccine Compositions
US19/323,644 US20260007740A1 (en) 2018-05-04 2025-09-09 Vaccine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1807376.7A GB201807376D0 (en) 2018-05-04 2018-05-04 HMCV Vaccine Composition

Publications (1)

Publication Number Publication Date
GB201807376D0 true GB201807376D0 (en) 2018-06-20

Family

ID=62598342

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1807376.7A Ceased GB201807376D0 (en) 2018-05-04 2018-05-04 HMCV Vaccine Composition

Country Status (1)

Country Link
GB (1) GB201807376D0 (en)

Similar Documents

Publication Publication Date Title
SG11202010821TA (en) Vaccine composition
GB201711635D0 (en) Immunogenic composition
GB201810492D0 (en) Composition
GB201804434D0 (en) Composition
GB201802339D0 (en) Immunogenic composition
SG11202009147UA (en) Vaccine compositions
GB201811100D0 (en) Composition
GB201820878D0 (en) Composition
GB201812145D0 (en) Composition
GB201711637D0 (en) Immunogenic composition
GB201818827D0 (en) Composition
GB2562241B (en) Vaccine compositions
SG11202103389WA (en) Immunogenic compositions
GB201910794D0 (en) Vaccine
GB201815031D0 (en) Composition
GB201801596D0 (en) Composition
GB201810024D0 (en) Composition
GB201703529D0 (en) Vaccine composition
GB201911636D0 (en) Vaccine
GB201811382D0 (en) Vaccine
GB201803692D0 (en) Immunogenic composition
GB201819861D0 (en) Composition
EP3677276A4 (en) Vaccine composition
GB201815032D0 (en) Composition
GB201718251D0 (en) Vaccine Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)